Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-85
SponsorTel-Aviv Sourasky Medical Center

About this trial

This is a pilot study designed to assess the feasibility, adherence, and preliminary effects of a 6-week home-based gait training intervention using the Walking Tall mobile app in individuals with Parkinson's disease. The app delivers rhythmic auditory cues and motivational verbal prompts to promote gait improvements. Primary outcomes include daily walking duration and step count measured via wearable sensors; secondary outcomes include gait speed, balance, self-reported confidence, and usability.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria);

Hoehn & Yahr stage II-III (ON-medication state);

Able to walk independently for ≥5 minutes;

Stable medication for ≥1 month;

Disqualifiers

Musculoskeletal, neurological, or visual/hearing impairments affecting gait;

Cognitive impairments or severe behavioral symptoms;

History of stroke, severe TBI, or brain tumor;

Cardiovascular contraindications;

Trial design

Design model

Single group

Treatments tested in this trial

  • Walking Tall App

    Behavioral

    Participants will use the Walking Tall smartphone app to complete 4-5 home-based walking sessions per week for 6 weeks. The app provides rhythmic auditory cues and verbal prompts to improve gait quality.

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Walking Tall App InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Average Step Count Per Day

Measured via accelerometer

Time frame
Time Frame: Baseline and 6 weeks
2

Daily Walking Duration (minutes/week)

Measured using tri-axial accelerometer (Axivity) over 7 days

Time frame
Time Frame: Baseline and 6 weeks

Secondary outcomes

1

Gait Speed (m/s) - single- and dual-task

Assessed using a 1-minute walking test under two conditions: (1) single-task (normal walking) and (2) dual-task (walking while performing a cognitive task such as serial subtraction). Gait speed is calculated in meters per second based on distance walked over time in each condition.

Time frame
Time Frame: Baseline and 6 weeks
2

Short Physical Performance Battery (SPPB)

The SPPB is a standardized test that evaluates lower extremity function using three components: balance (side-by-side, semi-tandem, tandem stance), gait speed over a 4-meter walk, and chair stands. Each component is scored from 0 to 4, with a total score ranging from 0 (worst performance) to 12 (best performance).

Time frame
Time Frame: Baseline and 6 weeks
3

Timed Up and Go (TUG) - single- and dual-task

The TUG test measures functional mobility by timing how long it takes a participant to stand up from a chair, walk 3 meters, turn, return, and sit down. It is performed under two conditions: (1) single-task (normal walking) and (2) dual-task (walking while performing a cognitive task, such as serial subtraction). The test evaluates gait, balance, and cognitive-motor integration.

Time frame
Time Frame: Baseline and 6 weeks

Other outcomes

1

Self-reported questionnaires: Activities-specific Balance Confidence (ABC)

Activities-specific Balance Confidence (ABC) Scale A 16-item self-report questionnaire assessing participants' confidence in performing various daily activities without losing balance or becoming unsteady. Scores range from 0% (no confidence) to 100% (complete confidence), with higher scores indicating greater balance confidence.

Time frame
Time Frame: Baseline and 6 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.